LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0550
-0.0050 (-8.33%)
Mar 5, 2026, 12:11 PM EST
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $2.27 million as of March 5, 2026. Its market cap has decreased by -95.68% in one year.
Market Cap
2.27M
Enterprise Value
55.50M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from 227.76M to 2.27M, a decrease of -99.00%. That is a compound annual growth rate of -63.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 2.27M | -93.45% |
| Dec 31, 2025 | 34.62M | -47.56% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enzolytics | 2.42M |
| VitaSpring Biomedical | 2.30M |
| Vaccinex | 2.68M |
| ProtoKinetix | 2.73M |
| Clearside Biomedical | 2.20M |
| Sorrento Therapeutics | 2.17M |
| ZyVersa Therapeutics | 2.15M |
| Agentix | 1.94M |